These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26118895)

  • 1. Molecular profiling of gliomas: potential therapeutic implications.
    Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
    Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
    Wirsching HG; Weller M
    Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic gliomas in adults: an update.
    Izquierdo C; Joubert B; Ducray F
    Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive biomarkers in adult gliomas: the present and the future.
    Thomas L; Di Stefano AL; Ducray F
    Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic glioma.
    Wick W; Wiestler B; Platten M
    Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personalized therapy for gliomas].
    Wick W; Hau P
    Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of gliomas].
    Lévy S; Chapet S; Mazeron JJ
    Cancer Radiother; 2014 Oct; 18(5-6):461-7. PubMed ID: 25201633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma biology and molecular markers.
    Cohen AL; Colman H
    Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic and predictive factors for gliomas in adults].
    Frenel JS; Botti M; Loussouarn D; Campone M
    Bull Cancer; 2009 Apr; 96(4):357-67. PubMed ID: 19357011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of diffusely infiltrating glioma in the elderly.
    Wirsching HG; Happold C; Roth P; Weller M
    Curr Opin Oncol; 2015 Nov; 27(6):502-9. PubMed ID: 26397765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
    Grant R; Kolb L; Moliterno J
    CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
    Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
    Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic glioma: current treatment and management.
    Le Rhun E; Taillibert S; Chamberlain MC
    Expert Rev Neurother; 2015 Jun; 15(6):601-20. PubMed ID: 25936680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma Subclassifications and Their Clinical Significance.
    Chen R; Smith-Cohn M; Cohen AL; Colman H
    Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling.
    Soffietti R; Franchino F; Magistrello M; Pellerino A; Rudà R
    Prog Neurol Surg; 2018; 31():168-179. PubMed ID: 29393185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.